Morgan Stanley’s UpHealth, Inc. UPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,772
Closed -$1.74K 8071
2023
Q3
$1.74K Hold
1,772
﹤0.01% 7153
2023
Q2
$3.33K Sell
1,772
-3
-0.2% -$5 ﹤0.01% 7077
2023
Q1
$2.64K Hold
1,775
﹤0.01% 7187
2022
Q4
$2.89K Buy
1,775
+496
+39% +$1.93K ﹤0.01% 7281
2022
Q3
$7K Sell
1,279
-1,098
-46% -$6.56K ﹤0.01% 7198
2022
Q2
$14K Sell
2,377
-453
-16% -$3.52K ﹤0.01% 7121
2022
Q1
$33K Buy
2,830
+653
+30% +$14.4K ﹤0.01% 6912
2021
Q4
$49K Buy
2,177
+803
+58% +$18.6K ﹤0.01% 6830
2021
Q3
$44K Buy
1,374
+250
+22% +$13.1K ﹤0.01% 6783
2021
Q2
$75K Sell
1,124
-272
-19% -$25.6K ﹤0.01% 6479
2021
Q1
$140K Buy
1,396
+1,392
+34,800% +$144K ﹤0.01% 5851
2020
Q4
$0 Buy
+4
New +$412 ﹤0.01% 7174
2020
Q3
Sell
-23
Closed -$2K 6892
2020
Q2
$2K Hold
23
﹤0.01% 6479
2020
Q1
$2K Sell
23
-447
-95% -$44.5K ﹤0.01% 6423
2019
Q4
$47K Buy
470
+389
+480% +$38.4K ﹤0.01% 5879
2019
Q3
$8K Buy
+81
New +$7.94K ﹤0.01% 6280

Other funds holding UPH

Morgan Stanley's UPH Position: Q4 2023 in Review

Morgan Stanley sold out of UpHealth, Inc. (UPH) in Q4 2023, closing a stake of 1,772 shares — an estimated $1.74K sold.

Morgan Stanley first reported a position in UPH in Q3 2019 and held it in 16 quarters. The position peaked at $140K in Q1 2021. 5 funds tracked by Wall St. Rank hold UPH as of Q4 2023.

  • Morgan Stanley reported no remaining UpHealth, Inc. position as of Q4 2023 after selling out during the quarter.
  • Morgan Stanley sold 1,772 UpHealth, Inc. shares in Q4 2023, an estimated $1.74K.
  • Morgan Stanley first reported a position in UpHealth, Inc. in Q3 2019 and held it in 16 quarters.
  • Morgan Stanley's UpHealth, Inc. position peaked at $140K in Q1 2021.
  • 5 funds tracked by Wall St. Rank held UpHealth, Inc. as of Q4 2023.

Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.